ð ç« æ«éèš
- Measles: paramyxovirus, R0 12-18 (most contagious), 3 Câs prodrome, Koplik spots, cephalocaudal rash; pneumonia + SSPE + immune amnesia
- Vitamin A for measles (WHO)
- Mumps: parotitis main; complications orchitis (~ 20% males), aseptic meningitis, hearing loss
- Rubella: mild adult; CRS in 1st trimester maternal (hearing loss + cataracts + cardiac PDA + microcephaly + âblueberry muffinâ)
- MMR: live attenuated, 2-dose 12-15 mo + 4-6 yr, 97% measles + rubella efficacy, 88% mumps
- Contraindications: pregnancy + severe immunocompromise
- 2024-2025 outbreaks: USA + Europe + Asia rising; vaccine hesitancy major driver
- Post-exposure: MMR < 72 hr or IG < 6 days
- SSPE: 5-15 yr post-measles, fatal
- Immune amnesia: measles wipes pre-existing antibody â argument for vaccination
- Americas eliminated 2015 (re-introductions occur)